J06BB05 • human anti-rabies immunoglobulin • Antiinfectives for systemic use | Immunoglobulins | Specific immunoglobulins
Human rabies immunoglobulin is a plasma-derived product used to prevent rabies in individuals exposed to the rabies virus, usually through bites from infected animals. It provides passive immunity by supplying specific antibodies against the rabies virus.
The medication is administered via intramuscular injection, as directed by a doctor, and is used in combination with the rabies vaccine.
Side effects may include pain at the injection site, fever, allergic reactions, or, in rare cases, anaphylactic reactions.
Patients should inform their doctor about any known allergies or other medications they are taking. Pregnant or breastfeeding women should consult a specialist before use.
Substance: human anti-rabies immunoglobulin
Date of last drug list: 01-06-2017
Commercial code: W63474001
Concentration: 150UI / ml
Pharmaceutical form: injectible solution
Quantity: 1
Product type: generic
Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).